IMCR stock gains after bullish views at Barclays ahead of tumor …

Nov 30, 2022 · Immunocore draws bullish views at Barclays ahead of data for tumor candidate. Nov. 30, 2022 1:41 PM ET Immunocore Holdings plc (IMCR) Stock ... and expect IMCR …

$92.00
OFF

Barclays Gives A Buy Rating To Immunocore Holdings (IMCR)

2 weeks from now

Jul 24, 2024 · Barclays analyst Peter Lawson assigned a Buy rating to Immunocore Holdings (IMCR – Research Report) today and set a price target of $92.00...

businessinsider.com

$66.00
OFF

Barclays Gives A Buy Rating To Immunocore Holdings (IMCR)

2 weeks from now

Sep 25, 2024 · Barclays analyst Peter Lawson assigned a Buy rating to Immunocore Holdings (IMCR – Research Report) today and set a price target of $66.00. The company’s shares …

businessinsider.com

82%
OFF

Does Immunocore (IMCR) Have The Potential To Rally 112.82% As …

2 weeks from now

Nov 28, 2024 · Shares of Immunocore Holdings PLC Sponsored ADR (IMCR Quick Quote IMCR - Free Report) have gained 2.9% over the past four weeks to close the last trading session at …

zacks.com

82%
OFF

Does Immunocore (IMCR) Have The Potential To Rally 112.82% As …

2 weeks from now

Nov 28, 2024 · The average of price targets set by Wall Street analysts indicates a potential upside of 112.8% in Immunocore (IMCR). While the effectiveness of this highly sought-after …

yahoo.com

13%
OFF

IMCR Stock: Biotech's Drug Pipeline Expanding From Melanoma …

2 weeks from now

Feb 13, 2023 · Investors may want to be cautious ahead of the earnings report. Also, one strategy around earnings would use call options . Through Friday's close IMCR stock had climbed 13% …

investors.com

5%
OFF

Immunocore Holdings PLC Sponsored ADR (IMCR) Surges 6.5%: Is …

2 weeks from now

Feb 14, 2023 · Immunocore Holdings PLC Sponsored ADR (IMCR Quick Quote IMCR - Free Report) shares ended the last trading session 6.5% higher at $65.71.The jump came on an …

zacks.com

9%
OFF

Immunocore Holdings PLC Sponsored ADR (IMCR) Outpaces Stock …

2 weeks from now

Immunocore Holdings PLC Sponsored ADR (IMCR) closed the most recent trading day at $64.51, moving +1.9% from the previous trading session. The stock outpaced the S&P 500's daily gain …

nasdaq.com

71%
OFF

Immunocore Holdings PLC Sponsored ADR (IMCR) Stock Sinks As …

2 weeks from now

Mar 30, 2023 · Immunocore Holdings PLC Sponsored ADR (IMCR) closed at $47.52 in the latest trading session, marking a -0.71% move from the prior day. This change lagged the S&P 500's …

nasdaq.com

56%
OFF

Wall Street Analysts Predict An 112.56% Upside In Immunocore …

2 weeks from now

Nov 8, 2024 · The average of price targets set by Wall Street analysts indicates a potential upside of 112.6% in Immunocore (IMCR). While the effectiveness of this highly sought-after metric is …

zacks.com

FAQs about IMCR stock gains after bullish views at Barclays ahead of tumor … Coupon?

Where can I buy Immunocore (IMCR) stock?

Immunocore (IMCR) stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. ...

What are the share price targets for IMCR?

The IMCR share price targets range from $16.00 to $91.00. On average, analysts predict the company's share price to reach $75.15 in the next twelve months, suggesting a possible upside of 23.5% from the current stock price. ...

Is Immunocore (imcr) a good stock to buy?

While Immunocore ( IMCR) trades at 7x cash after YTD outperformance, “we are positive on the risk/reward ahead of 4Q22 and 2023 data that could help validate the breadth of Immunocore’s bispecific TCR platform,” Lawson and the team wrote. ...

Is there a potential upside in imcr?

That's because the ability and unbiasedness of analysts in setting price targets have long been questionable. However, an impressive consensus price target is not the only factor that indicates a potential upside in IMCR. ...

Should you buy Immunocore Holdings plc sponsored ADR (imcr)?

Immunocore Holdings PLC Sponsored ADR (IMCR) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture. ...

Did IMCR raise $199 million in an IPO?

IMCR raised $199 million in an initial public offering (IPO) on February 5th 2021. They issued 8,300,000 shares at $23.00-$25.00 per share. Goldman Sachs, J.P. Morgan and Jefferies acted as the underwriters for the IPO. ...